Oil Prices Rise On New Stimulus Hopes By Julianne Geiger

New Post Public Reply Private Reply Replies (1) Message Board
SaltyMutt
211
Oil Prices Rise On New Stimulus Hopes

By Julianne Geiger - Jan 14, 2021

2021-01-14_0nxmphldnc.jpg

Oil prices were up on Thursday afternoon despite new and extended lockdowns that promise to slow any oil demand rebound that was expected for 2021.

At 4:07 p.m. EST, WTI crude was trading at $53.61 per barrel, up $.70 (+1.32%) on the day. Brent crude was trading up $0.28 (0.43%) on the day at $56.30.

This comes even as China locks down more than 22 million citizens amid a new wave of Covid-19, on top of announcements that there will be extended curfews in France that will last 12 hours of the day, beginning on Saturday.

In fact, Europe’s oil demand has failed to start the year with any sort of bang, slumping 1.76 million barrels per day so far this month, according to Rystad Energy, as road use in the UK, France, Italy, and Spain fell 37% last week compared with pre-virus levels.

Bolstering oil prices, particularly WTI, is the hope that the incoming Biden administration will quickly push through yet another round of stimulus payments in the amount of $1400 per person. This will add onto the current $600 payments that are being distributed now.

Also serving as a catalyst for rising prices are analyst rumors of a tightening of supply, despite the persistently low oil demand. Crude oil inventories in the United States were down for the second week in a row, the EIA reported on Wednesday.

Still, gasoline and distillate inventories are growing, even though production for the fuels is also down.

The market is now hoping that an influx of cash will prop up this sluggish demand.

Both benchmarks are trading at an 11-month high.

By Julianne Geiger for Oilprice.com

https://oilprice.com/Energy/Oil-Prices/Oil-Pr...Hopes.html
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Molina Healthcare: Anticipating Earnings and Market Movements

Updated Category News Views 138

Molina Healthcare's Upcoming Earnings Announcement Molina Healthcare (NYSE: MOH) is on the verge of releasing its quarterly earnings report, and investors are on high alert. The anticipated announcement will unfold on a Wednesday in the near future, and expectations are building around the company's performance. Understanding Earnings Expectations Analysts have projected...

Continue Reading
Innovative Sportswear Design Award by ANTA and Tsinghua University

Updated Category News Views 121

Introducing the 3rd Global Sportswear Design Award On an inspiring day in June, the 3rd Global Sportswear Design Award kicked off, marking a significant milestone in the world of sportswear design. This prestigious event, held at the China National Silk Museum, is a collaboration between ANTA Group and Tsinghua University. The central theme for this year's award is...

Continue Reading
Boeing's Speculation: What Lies Ahead for Its Stock?

Updated Category News Views 189

Understanding Boeing's Recent Stock Decline Boeing Company (NYSE: BA) shares experienced a noticeable drop recently. This decline followed a significant directive from the Federal Trade Commission (FTC) that requires Boeing to divest a considerable portion of its assets linked to Spirit Aerosystems Holdings, Inc. (NYSE: SPR). The market responded quickly, reflecting...

Continue Reading
Commitment to Recovery: Resilience in the Face of Disasters

Updated Category News Views 194

A Commitment to Community Resilience In recent times, our world has witnessed unprecedented weather events that remind us of the importance of community and resilient governance. Following a rare and intense rainfall that devastated many areas, community members are on the road to recovery, showcasing hope and togetherness. Devastation and Hope in Hard-Hit Regions In one...

Continue Reading
Eledon Pharmaceuticals Advances Tegoprubart for Kidney Care

Updated Category News Views 226

Exciting Advances in Kidney Transplant Rejection Prevention Recent findings from Eledon Pharmaceuticals, Inc. showcase significant results from the Phase 2 BESTOW trial, where Tegoprubart has emerged as a promising contender for preventing rejection in kidney transplant patients. Patients who continued on Tegoprubart for a year post-transplant revealed an impressive...

Continue Reading